Mylan buys rights to Israel-developed Multiple Sclerosis treatment | Times of Israel MS drug developed by Mapi Pharma requires a once-monthly injection instead of 3 times a week HIER WEITERLESEN: WWW.TIMESOFISRAEL.COM
Iran holds missile drills amid rising tensions, as Israel watches for signs of imminent attack – Tehran says missiles are for deterrence and not open to negotiation, while reports suggest missile production could reach 3,000 annually; Israeli and US officials warn drills may mask preparations for surprise strike or military escalation | ynetglobal 22.12.2025
Holocaust survivors and former Gaza hostages meet, reflect on trauma and Jewish identity – Held ahead of Hanukkah, the encounters highlight shared memories of survival, moments of faith and ‘small miracles’ and the role of remembrance and resilience in shaping Jewish continuity after Oct. 7 ynetglobal 19.12.2025
Dein Wochenüberblick: ILI News 22.12.2025 – WAFFENSTILLSTAND UND HOFFNUNG AUF FRIEDEN | ILI – I LIKE ISRAEL e.V.” 22.12.2025
Leave a Reply
You must belogged in to post a comment.